Nasal Drug Delivery Devices Market (By Product: Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer; By Application: Asthma, Chronic Obstructive Pulmonary Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Nasal Drug Delivery Devices
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Nasal Drug Delivery Devices Market By Product
     1.2.2.1. Global Nasal Drug Delivery Devices Market Revenue and Growth Rate Comparison By Product (2016-2027)
     1.2.2.2. Global Nasal Drug Delivery Devices Market Revenue Share By Product in 2019
       1.2.2.2.1. Dry Powder Inhaler
       1.2.2.2.2. Metered Dose Inhaler
       1.2.2.2.3. Nebulizer
   1.2.3. Nasal Drug Delivery Devices Market By Application
     1.2.3.1. Global Nasal Drug Delivery Devices Market Revenue and Growth Rate Comparison By Application (2016-2027)
       1.2.3.1.1. Asthma
       1.2.3.1.2. Chronic Obstructive Pulmonary Diseases
       1.2.3.1.3. Others
   1.2.4. Nasal Drug Delivery Devices Market By Distribution Channel
     1.2.4.1. Global Nasal Drug Delivery Devices Market Revenue and Growth Rate Comparison By Distribution Channel (2016-2027)
     1.2.4.2. Hospital Pharmacies
     1.2.4.3. Retail Pharmacies
     1.2.4.4. Online Pharmacies
   1.2.5. Nasal Drug Delivery Devices Market By Geography
     1.2.5.1. Global Nasal Drug Delivery Devices Market Revenue and Growth Rate Comparison By Geography (2016-2027)
     1.2.5.2. North America Nasal Drug Delivery Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.3. Europe Nasal Drug Delivery Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.4. Asia-Pacific Nasal Drug Delivery Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.5. Latin America Nasal Drug Delivery Devices Market Revenue and Growth Rate(2016-2027)
     1.2.5.6. Middle East and Africa (MEA)Nasal Drug Delivery Devices Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Nasal Drug Delivery Devices Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Nasal Drug Delivery Devices Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Nasal Drug Delivery Devices Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Nasal Drug Delivery Devices Major Manufacturers in 2019

CHAPTER 4. NASAL DRUG DELIVERY DEVICES MARKET BY PRODUCT
4.1. Global Nasal Drug Delivery Devices Revenue By Product
4.2. Dry Powder Inhaler
   4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Metered Dose Inhaler
   4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Nebulizer
   4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 5. NASAL DRUG DELIVERY DEVICES MARKET BY APPLICATION
5.1. Global Nasal Drug Delivery Devices Revenue By Application
5.2. Asthma
   5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Chronic Obstructive Pulmonary Diseases
   5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.4. Others
   5.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 6. NASAL DRUG DELIVERY DEVICES MARKET BY DISTRIBUTION CHANNEL
6.1. Global Nasal Drug Delivery Devices Revenue By Distribution Channel
6.2. Hospital Pharmacies
   6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Retail Pharmacies
   6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Online Pharmacies
   6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 7. NORTH AMERICA NASAL DRUG DELIVERY DEVICES MARKET BY COUNTRY
7.1. North America Nasal Drug Delivery Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. North America Nasal Drug Delivery Devices Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. U.S.
   7.3.1. U.S. Nasal Drug Delivery Devices Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   7.3.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   7.4.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)

CHAPTER 8. EUROPE NASAL DRUG DELIVERY DEVICES MARKET BY COUNTRY
8.1. Europe Nasal Drug Delivery Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Europe Nasal Drug Delivery Devices Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   8.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   8.5.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   8.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   8.6.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   8.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   8.7.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)

CHAPTER 9. ASIA-PACIFIC NASAL DRUG DELIVERY DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Nasal Drug Delivery Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Asia-Pacific Nasal Drug Delivery Devices Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   9.8.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   9.8.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)

CHAPTER 10. LATIN AMERICA NASAL DRUG DELIVERY DEVICES MARKET BY COUNTRY
10.1. Latin America Nasal Drug Delivery Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Latin America Nasal Drug Delivery Devices Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA NASAL DRUG DELIVERY DEVICES MARKET BY COUNTRY
11.1. Middle East & AFRICA Nasal Drug Delivery Devices Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Middle East & AFRICA Nasal Drug Delivery Devices Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)
11.5. Rest of Middle East & AFRICA
   11.5.1. Market Revenue and Forecast By Product, 2016 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Distribution Channel, 2016 - 2027 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Consort Medical plc.
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Vectura Group plc.
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. 3M
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Nemera
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. Aptar Group Inc.
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. H&T Presspart Manufacturing Ltd.
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Teva Pharmaceutical Ltd.
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Gofire Inc.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. AstraZeneca
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Others
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Type Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope


Cart Summary